200 percent increase in cardiovascular medication costs to $5 billion in Canada

The number of prescriptions in Canada for cardiovascular medications has been increasing over the past decade, with a 200% increase in costs, found a new study in CMAJ (Canadian Medical Association Journal). In 2006, total costs of cardiovascular medications exceeded $5 billion, with statins accounting for almost 40% of the expenditure.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news166118049.html">200 percent increase in cardiovascular medication costs to $5 billion in Canada</a></p> <p>The number of prescriptions in Canada for cardiovascular medications has been increasing over the past decade, with a 200% increase in costs, found a new study in <i>CMAJ</i> (<i>Canadian Medical Association Journal</i>). In 2006, total costs of cardiovascular medications exceeded $5 billion, with statins accounting for almost 40% of the expenditure.</p>